Efficacy and Safety of Rituximab Biosimilar Candidate (CTP10) and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase I Randomized Controlled Trial over 72 weeks

  • 유대현
제목
Efficacy and Safety of Rituximab Biosimilar Candidate (CTP10) and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase I Randomized Controlled Trial over 72 weeks
저자
유대현
발행일
2015-11-09
학회명
ACR 2015
개최지
San Francisco, USA